JP5230447B2 - 新規方法 - Google Patents

新規方法 Download PDF

Info

Publication number
JP5230447B2
JP5230447B2 JP2008553741A JP2008553741A JP5230447B2 JP 5230447 B2 JP5230447 B2 JP 5230447B2 JP 2008553741 A JP2008553741 A JP 2008553741A JP 2008553741 A JP2008553741 A JP 2008553741A JP 5230447 B2 JP5230447 B2 JP 5230447B2
Authority
JP
Japan
Prior art keywords
gene
thymidine
thf
plasmid
udr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008553741A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009525738A5 (https=
JP2009525738A (ja
Inventor
デイビッド・マーティン・アンダーソン
アンドリュー・ジョン・コリス
リン・リュー
セルゲイ・ポドコビロフ
クリストファー・プレストン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of JP2009525738A publication Critical patent/JP2009525738A/ja
Publication of JP2009525738A5 publication Critical patent/JP2009525738A5/ja
Application granted granted Critical
Publication of JP5230447B2 publication Critical patent/JP5230447B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • C12P19/385Pyrimidine nucleosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
JP2008553741A 2006-02-06 2007-02-05 新規方法 Expired - Fee Related JP5230447B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0602339.4 2006-02-06
GBGB0602339.4A GB0602339D0 (en) 2006-02-06 2006-02-06 Novel process
PCT/EP2007/051072 WO2007090810A1 (en) 2006-02-06 2007-02-05 Novel process

Publications (3)

Publication Number Publication Date
JP2009525738A JP2009525738A (ja) 2009-07-16
JP2009525738A5 JP2009525738A5 (https=) 2012-09-20
JP5230447B2 true JP5230447B2 (ja) 2013-07-10

Family

ID=36101118

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008553741A Expired - Fee Related JP5230447B2 (ja) 2006-02-06 2007-02-05 新規方法

Country Status (9)

Country Link
US (1) US8263384B2 (https=)
EP (2) EP1981972B1 (https=)
JP (1) JP5230447B2 (https=)
KR (1) KR101371954B1 (https=)
CN (1) CN101379185B (https=)
ES (1) ES2410857T3 (https=)
GB (1) GB0602339D0 (https=)
SI (1) SI1981972T1 (https=)
WO (1) WO2007090810A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8770862B2 (en) 2007-01-24 2014-07-08 Adc Telecommunications, Inc. Hardened fiber optic connector

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010518837A (ja) * 2007-02-19 2010-06-03 エボニック デグサ ゲーエムベーハー ホルメート−thf−シンテターゼおよび/またはグリシン開裂活性を有するコリネ型細菌
CN113755416B (zh) * 2020-06-05 2023-08-15 苏州华赛生物工程技术有限公司 具有新合成路径生产β-胸苷的重组微生物及生产β-胸苷的方法
CN111748537B (zh) * 2020-08-04 2021-11-26 浙江华睿生物技术有限公司 一种尿苷磷酸酶突变体及其应用
KR102398032B1 (ko) * 2020-09-22 2022-05-19 비피진 주식회사 암 치료를 위한 5''-뉴클레오티다아제 변이체
CN112126666B (zh) * 2020-09-22 2022-04-08 廊坊梅花生物技术开发有限公司 核苷高产菌及其构建方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68916708T2 (de) 1988-05-31 1994-12-01 Zeneca Ltd Herstellung eines Desoxyribonucleosids.
US5213972A (en) * 1989-12-08 1993-05-25 Chemgen Corporation Fermentation process for the production of pyrimidine deoxyribonucleosides
JP3916345B2 (ja) 1999-06-26 2007-05-16 均 西谷 両開きドア
DE60035781T2 (de) * 1999-07-01 2008-08-07 Glaxo Group Ltd., Greenford Vektoren, zellen und verfahren zur herstellung von pyrimidindeoxyribonucleosiden

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8770862B2 (en) 2007-01-24 2014-07-08 Adc Telecommunications, Inc. Hardened fiber optic connector
US10877224B2 (en) 2007-01-24 2020-12-29 Commscope Technologies Llc Fiber optic adapter
US11409057B2 (en) 2007-01-24 2022-08-09 Commscope Technologies Llc Hardened fiber optic connector

Also Published As

Publication number Publication date
GB0602339D0 (en) 2006-03-15
EP2287294A1 (en) 2011-02-23
EP1981972A1 (en) 2008-10-22
WO2007090810A1 (en) 2007-08-16
US20090081735A1 (en) 2009-03-26
JP2009525738A (ja) 2009-07-16
KR101371954B1 (ko) 2014-03-07
US8263384B2 (en) 2012-09-11
KR20080093118A (ko) 2008-10-20
EP1981972B1 (en) 2013-03-20
ES2410857T3 (es) 2013-07-03
CN101379185B (zh) 2012-08-29
CN101379185A (zh) 2009-03-04
SI1981972T1 (sl) 2013-07-31

Similar Documents

Publication Publication Date Title
CN103443267B (zh) L-氨基酸生产力增强的微生物及利用其产生l-氨基酸的方法
JP7125477B2 (ja) グリシン生産能が増加された微生物及びこれを用いた発酵組成物の生産方法
US10633684B2 (en) Production of riboflavin
JP2019501638A (ja) ニコチンアミドリボシドの微生物生産
KR101611036B1 (ko) 대장균에서 대사공학적 방법을 이용한 데옥시사이티딘 생산 균주 개발
JP5230447B2 (ja) 新規方法
RU2306338C2 (ru) Mob'-ПРОИЗВОДНАЯ ПЛАЗМИДА RSF1010, НЕ СОДЕРЖАЩАЯ ГЕНЫ УСТОЙЧИВОСТИ К АНТИБИОТИКАМ, БАКТЕРИЯ, СОДЕРЖАЩАЯ УКАЗАННУЮ ПЛАЗМИДУ, И СПОСОБ ПОЛУЧЕНИЯ ПОЛЕЗНЫХ МЕТАБОЛИТОВ
JP2002512802A (ja) 芳香族代謝/iii物質の微生物による製造
JP4352716B2 (ja) バチルス属に属するイノシン生産菌及びイノシンの製造法
JP2002512802A6 (ja) 芳香族代謝/iii物質の微生物による製造
CN116004489B (zh) 一种生产nmn的重组大肠杆菌及其应用
KR101653245B1 (ko) 대장균에서 대사공학적 방법을 이용한 싸이미딘의 대량생산 방법
US20020128457A1 (en) Vectors, cells and processes for pyrimidine deoxyribonucleosides production
JP5364376B2 (ja) 改変型トランスケトラーゼおよびその使用
CN117897476A (zh) 生产维生素b化合物的微生物细胞工厂
Vybornaya et al. Use of an alternative pathway for isoleucine synthesis in threonine-producing strains of Escherichia coli
US7387893B2 (en) Vectors, cells and processes for pyrimidine deoxyribonucleosides production
Bubnov et al. Glutamyl-and Glutaminyl-tRNA synthetases are a promising target for the design of an L-Threonine–producing strain
Straube et al. L-Lysine production from glucose and chitin monomers using engineered Vibrio natriegens
Takeno et al. Significance of the Cgl1427 gene encoding cytidylate kinase in microaerobic growth of Corynebacterium glutamicum
KR100859088B1 (ko) L-쓰레오닌 생산 변이주 및 이를 이용한 l-쓰레오닌생산 방법
CN121931022A (zh) 一种产l-色氨酸重组菌及其构建方法和应用
KR20240086805A (ko) 퓨린 뉴클레오티드를 생산하는 미생물 및 이를 이용한 퓨린 뉴클레오티드의 생산방법
EP1806405A2 (en) Vectors, cells and processes for pyrimidine deoxyribonucleosides production

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100105

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20120309

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120508

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20120806

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121002

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121228

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130110

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130125

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130219

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130319

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160329

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5230447

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees